Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov;27(11):2604-2609.
doi: 10.1002/ejhf.3570. Epub 2025 Jan 10.

Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF)

Joanna Osmanska  1 , Kieran F Docherty  1 , Colin Berry  1 , Pardeep S Jhund  1 , Kenneth Mangion  1 , Patrick B Mark  1 , John J V McMurray  1 , Giles Roditi  1 , Naveed Sattar  1 , Mark C Petrie  1 , Ross T Campbell  1 , Matthew M Y Lee  1
Affiliations

Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF)

Joanna Osmanska et al. Eur J Heart Fail. 2025 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between baseline cardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure (CMR‐PCWP) and baseline characteristics including circulating and ultrasound‐based measures. Data are presented as correlation heatmap with Pearson correlation coefficients. 6MWT, 6‐min walk test; CA‐125, carbohydrate antigen 125; estPASP, estimated pulmonary artery systolic pressure; GDF‐15, growth differentiation factor‐15; KCCQ‐CSS, Kansas City Cardiomyopathy Questionnaire clinical summary score; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; SBP, systolic blood pressure.
Figure 2
Figure 2
Correlation between baseline cardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure (CMR‐PCWP) and baseline CMR‐derived measurements. Data are presented as correlation heatmap with Pearson correlation coefficients. LAV, left atrial volume; LV, left ventricular; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end‐systolic volume; LVSV, left ventricular stroke volume; RVEDV, right ventricular end‐diastolic volume; RVEF, right ventricular ejection fraction; RVESV, right ventricular end‐systolic volume; RVSV, right ventricular stroke volume.
Figure 3
Figure 3
Change in cardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure (CMR‐PCWP) from baseline to 36 weeks. CI, confidence interval.
See this image and copyright information in PMC

References

    1. Garg P, Gosling R, Swoboda P, Jones R, Rothman A, Wild JM, et al. Cardiac magnetic resonance identifies raised left ventricular filling pressure: Prognostic implications. Eur Heart J 2022;43:2511–2522. 10.1093/eurheartj/ehac207 - DOI - PMC - PubMed
    1. Thomson RJ, Grafton‐Clarke C, Matthews G, Swoboda PP, Swift AJ, Frangi A, et al. Risk factors for raised left ventricular filling pressure by cardiovascular magnetic resonance: Prognostic insights. ESC Heart Fail 2024;11:4148–4159. 10.1002/ehf2.15011 - DOI - PMC - PubMed
    1. Lee MMY, Brooksbank KJM, Wetherall K, Mangion K, Roditi G, Campbell RT, et al. Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR‐DM‐HF). Circulation 2021;143:516–525. 10.1161/CIRCULATIONAHA.120.052186 - DOI - PMC - PubMed
    1. Mullens W, Dauw J, Martens P, Meekers E, Nijst P, Verbrugge FH, et al. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): Baseline characteristics. Eur J Heart Fail 2022;24:1601–1610. 10.1002/ejhf.2587 - DOI - PubMed
    1. Ern Yeoh S, Osmanska J, Petrie MC, Brooksbank KJM, Clark AL, Docherty KF, et al. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Eur Heart J 2023;44:2966–2977. 10.1093/eurheartj/ehad341 - DOI - PMC - PubMed